What are the management options for vestibular migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vestibular Migraine: Diagnosis and Management

Diagnostic Criteria

Vestibular migraine requires ≥5 episodes of vestibular symptoms lasting 5 minutes to 72 hours, current or history of migraine, ≥1 migraine symptom during at least 50% of dizzy episodes (migrainous headache, photophobia, phonophobia, visual or other aura), and exclusion of other causes by appropriate investigations. 1, 2

Key Diagnostic Features

  • Vestibular symptoms include spontaneous vertigo, triggered vertigo, positional vertigo, head-motion dizziness, or disequilibrium 3
  • Migraine features during attacks may include headache, photophobia, phonophobia, osmophobia, or visual aura 3
  • Lifetime prevalence is 3.2%, accounting for up to 14% of all vertigo cases 1, 2
  • Episodes often occur independently of headaches, making diagnosis challenging 4

Critical Differential Diagnoses to Exclude

  • Benign paroxysmal positional vertigo (BPPV): Distinguished by positional triggers and characteristic nystagmus on Dix-Hallpike maneuver 1
  • Central causes: Brainstem/cerebellar stroke, multiple sclerosis, intracranial tumors—look for focal neurologic deficits, dysarthria, dysmetria, dysphagia, or Horner's syndrome 1, 5
  • Ménière's disease: Characterized by hearing loss, which should be absent in vestibular migraine 6, 3
  • Vestibular neuritis: Presents with baseline nystagmus without provocative maneuvers 1

Management Algorithm

First-Line: Lifestyle Modifications

Begin with dietary and lifestyle modifications including limiting salt/sodium intake, avoiding excessive caffeine, alcohol, and nicotine, eating well-balanced meals, maintaining adequate hydration, managing stress, regular exercise, establishing regular sleep patterns, and identifying/managing allergies. 2

  • These interventions are recommended as first-line before pharmacological treatment 2
  • Patient education is essential to improve understanding and adherence 2

Acute Attack Treatment

Pharmacological Options for Acute Episodes

  • Triptans can be used to treat concurrent headache, most effective when taken early while headache is still mild 2, 7, 8
  • Vestibular suppressants (e.g., meclizine, diphenhydramine) help ameliorate acute symptoms but are not recommended for long-term use 2, 4
  • Antiemetic medications (e.g., diphenhydramine, meclizine) for nausea during attacks 2
  • Benzodiazepines (e.g., scopolamine) may help with acute symptoms but carry risk of drug dependence and significant side effects 2, 4

Critical Pitfall

  • Limit acute medication use to ≤2 days per week to prevent medication overuse headache 2, 5

Preventive Treatment

Preventive medications should be initiated when symptoms occur ≥2 days per month despite optimized acute treatment. 2, 5

First-Line Preventive Medications

Beta-blockers (propranolol, metoprolol, atenolol), topiramate, or candesartan are first-line preventive options. 2, 7, 5

  • Beta-blockers: Preferred in patients with hypertension but contraindicated in asthma 4
  • Topiramate: Preferred when patients are obese 4
  • Candesartan: Alternative first-line option 2

Second-Line Preventive Medications

  • Tricyclic antidepressants (amitriptyline, nortriptyline): Preferred if patients have comorbid anxiety 4, 6
  • Venlafaxine: SSRI option for patients with anxiety 4, 6
  • Valproic acid: Alternative anticonvulsant 4, 6
  • Lamotrigine: Preferred if vertigo is more frequent than headaches 4

Third-Line Preventive Medications

  • CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) can be used as third-line options 2
  • OnabotulinumtoxinA may be considered for chronic migraine with vestibular symptoms 2

Treatment Duration and Assessment

  • Assess efficacy of oral preventive medications after 2-3 months at therapeutic dose 2
  • Consider pausing treatment after 6-12 months of successful control to determine if preventive therapy can be stopped 2
  • For CGRP monoclonal antibodies, assess efficacy after 3-6 months 2
  • For onabotulinumtoxinA, assess efficacy after 6-9 months 2

Non-Pharmacological Approaches

Vestibular Rehabilitation

  • Vestibular rehabilitation is useful when there are complications such as loss of confidence in balance or visual dependence 4, 9
  • May be helpful as adjunctive therapy alongside pharmacological prevention 6

Behavioral Interventions

  • Stress reduction techniques, regular sleep schedule, and biobehavioral therapy can be effective 2
  • Identifying and avoiding migraine triggers is essential 4

Critical Pitfalls to Avoid

  • Do NOT use oral ergot alkaloids, opioids, or barbiturates due to questionable efficacy with considerable adverse effects and dependency risk 2
  • Avoid overuse of vestibular suppressant medications for long-term management 2
  • Do NOT abandon treatment prematurely—efficacy takes weeks to months to establish 2
  • Recognize and manage comorbidities such as anxiety, depression, and sleep disturbances 2
  • Failure to respond to conservative management should raise concern that the underlying diagnosis may not be vestibular migraine 1
  • Set realistic expectations that efficacy is rarely observed immediately and may take several weeks to months 2
  • Emphasize that failure of one preventive treatment does not predict failure of other drug classes 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vestibular Migraine Treatment and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vestibular Migraine: How to Sort it Out and What to Do About it.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2019

Research

Management of vestibular migraine.

Therapeutic advances in neurological disorders, 2011

Guideline

Diagnostic Approach to Headache and Lightheadedness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current Treatment Options: Vestibular Migraine.

Current treatment options in neurology, 2017

Guideline

Treatment Options for Ocular Migraines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vestibular migraine treatment: a comprehensive practical review.

Brain : a journal of neurology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.